An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples